Gendler Yulia
The Department of Nursing, School of Health Sciences, Ariel University, Ariel 40700, Israel.
Vaccines (Basel). 2023 May 29;11(6):1038. doi: 10.3390/vaccines11061038.
This study aimed to develop and evaluate the effectiveness of two web-based decision aids designed to help parents of children aged 10-17 years and young adults aged 18-26 years make informed decisions about the HPV vaccine.
The decision aids were developed according to the International Patient Decision Aid Standards (IPDAS) criteria and included information about the vaccine, probabilities of benefits and side effects, personal narratives, and values clarification. The study utilized a quasi-experimental design and included 120 Hebrew-speaking parents and 160 young adults. Participants completed baseline surveys and, two weeks after using the decision aid, completed a follow-up survey.
Both parents and young adults experienced a reduction in decisional conflict, an increase in self-efficacy, and greater confidence in the safety and effectiveness of the vaccine. The proportion of participating parents deciding to vaccinate their children against HPV increased from 46% to 75%, and the proportion of participating young adults leaning towards receiving the HPV vaccine increased from 64% to 92%.
The study highlights the importance of using decision aids to support informed decision making about vaccination and suggests that web-based decision aids may be a useful tool for supporting Israeli parents and young adults to make HPV vaccination decisions.
本研究旨在开发并评估两款基于网络的决策辅助工具的有效性,这两款工具旨在帮助10至17岁儿童的父母以及18至26岁的年轻人就人乳头瘤病毒(HPV)疫苗做出明智的决策。
决策辅助工具是根据国际患者决策辅助标准(IPDAS)标准开发的,包括有关疫苗的信息、益处和副作用的概率、个人叙述以及价值观澄清。该研究采用了准实验设计,纳入了120名说希伯来语的父母和160名年轻人。参与者完成了基线调查,并在使用决策辅助工具两周后完成了随访调查。
父母和年轻人在决策冲突方面均有所减少,自我效能感有所提高,并且对疫苗的安全性和有效性更有信心。决定为孩子接种HPV疫苗的参与研究的父母比例从46%增至75%,倾向于接种HPV疫苗的参与研究的年轻人比例从64%增至92%。
该研究突出了使用决策辅助工具来支持有关疫苗接种的明智决策的重要性,并表明基于网络的决策辅助工具可能是帮助以色列父母和年轻人做出HPV疫苗接种决策的有用工具。